Skip to main content

Candel Therapeutics, Inc.

CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001841387

In the last 90 days, Candel Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 137 institutions reported holding it in 13F filings for Q2 2026, worth $518.9M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Candel Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+25 vs. Q1 2024
Shares held
5.96M
+2.18M (+57.7%) vs. Q1 2024
Total value
$37.0M
+$31.0M (+518.9%) vs. Q1 2024
New holders
31
9 more added
Sold out
6
4 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CADL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 45 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 12 institutionsQ4 2021: 20 institutionsQ1 2022: 23 institutionsQ2 2022: 23 institutionsQ3 2022: 25 institutionsQ4 2022: 21 institutionsQ1 2023: 21 institutionsQ2 2023: 20 institutionsQ3 2023: 20 institutionsQ4 2023: 22 institutionsQ1 2024: 20 institutionsQ2 2024: 45 institutionsQ3 2024: 52 institutionsQ4 2024: 71 institutionsQ1 2025: 82 institutionsQ2 2025: 78 institutionsQ3 2025: 81 institutionsQ4 2025: 84 institutionsQ1 2026: 114 institutionsQ2 2026: 137 institutions
Value heldQ2 2024: $37.0M
Q1 2021: $0Q2 2021: $0Q3 2021: $52.9MQ4 2021: $54.4MQ1 2022: $34.0MQ2 2022: $20.6MQ3 2022: $19.1MQ4 2022: $9.70MQ1 2023: $7.44MQ2 2023: $6.77MQ3 2023: $4.86MQ4 2023: $5.92MQ1 2024: $5.97MQ2 2024: $37.0MQ3 2024: $46.4MQ4 2024: $155.7MQ1 2025: $119.7MQ2 2025: $116.6MQ3 2025: $115.6MQ4 2025: $133.5MQ1 2026: $212.9MQ2 2026: $518.9M
Institutions holding CADL and their total value by quarter
QuarterHoldersValue
Q2 2026137$518.9M
Q1 2026114$212.9M
Q4 202584$133.5M
Q3 202581$115.6M
Q2 202578$116.6M
Q1 202582$119.7M
Q4 202471$155.7M
Q3 202452$46.4M
Q2 202445$37.0M
Q1 202420$5.97M
Q4 202322$5.92M
Q3 202320$4.86M
Q2 202320$6.77M
Q1 202321$7.44M
Q4 202221$9.70M
Q3 202225$19.1M
Q2 202223$20.6M
Q1 202223$34.0M
Q4 202120$54.4M
Q3 202112$52.9M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Candel Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding CADL in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Northpond Ventures, LLC1,935,215$12.0M21.71%00.0%Unchanged
BlackRock Inc.823,071$5.10M0.00%+775,491+1,629.9%Added
Vanguard Group Inc818,550$5.08M0.00%+277,255+51.2%Added
State Street Corp472,798$2.93M0.00%+445,198+1,613.0%Added
Sands Capital Ventures, LLC405,837$2.52M0.84%−405,900−50.0%Reduced
Geode Capital Management, LLC397,886$2.47M0.00%+252,180+173.1%Added
Nuveen Asset Management, LLC382,188$2.37M0.00%+382,188New
Bridgeway Capital Management, LLC80,595$499.7K0.01%−2,000−2.4%Reduced
MML Investors Services, LLC73,376$455.0K0.00%+73,376New
Bank of America Corp54,449$337.6K0.00%+54,449New
Bank of New York Mellon Corp54,449$337.6K0.00%+54,449New
Charles Schwab Investment Management Inc46,777$290.0K0.00%+46,777New
Northern Trust Corp43,445$269.4K0.00%+23,938+122.7%Added
Cubist Systematic Strategies, LLC26,121$161.9K0.00%+26,121New
Advisor Group Holdings, Inc.25,800$160.0K0.00%+25,800New
Rhumbline Advisers22,985$142.5K0.00%+22,985New
Virtu Financial LLC22,639$140.0K0.01%+22,639New
Vontobel Holding Ltd.22,000$136.4K0.00%+22,000New
Schonfeld Strategic Advisors LLC21,452$133.0K0.00%+21,452New
Renaissance Technologies LLC20,600$127.7K0.00%−36,305−63.8%Reduced
Morgan Stanley19,458$120.6K0.00%+19,458New
JPMorgan Chase & Co19,358$120.0K0.00%+19,137+8,659.3%Added
Alpine Global Management, LLC18,761$116.3K0.02%+18,761New
Goldman Sachs Group Inc18,225$113.0K0.00%+18,225New
Millennium Management LLC17,344$107.5K0.00%+17,344New
New York State Common Retirement Fund17,000$105.4K0.00%+17,000New
Squarepoint Ops LLC12,238$75.9K0.00%+12,238New
Jane Street Group, LLC11,960$74.2K0.00%+11,960New
Janney Montgomery Scott LLC11,615$72.0K0.00%+11,615New
Corebridge Financial, Inc.10,660$66.2K0.00%+10,660New
Alliancebernstein L.P.10,660$66.1K0.00%+10,660New
Barclays PLC6,717$41.6K0.00%+6,717New
Wells Fargo & Company6,344$39.3K0.00%+6,229+5,416.5%Added
UBS Group AG6,005$37.2K0.00%+5,995+59,950.0%Added
Simplex Trading, LLC5,001$31.0K0.00%+5,001New
Point72 (DIFC) Ltd4,927$30.5K0.00%+4,927New
Citigroup Inc4,598$28.5K0.00%+4,598New
Royal Bank of Canada2,264$15.0K0.00%+2,195+3,181.2%Added
Legal & General Group Plc2,197$13.6K0.00%+2,197New
Ameritas Investment Partners, Inc.1,941$12.0K0.00%+1,941New
California State Teachers Retirement System1,436$8.90K0.00%+1,436New
Tower Research Capital LLC (TRC)1,252$7.76K0.00%−2,450−66.2%Reduced
Point72 Asia (Singapore) Pte. Ltd.813$5.04K0.00%+813New
Amalgamated Bank686$4.00K0.00%+686New
Deutsche Bank AG68$4220.00%+68New
Mariner, LLC0$00.00%−33,480−100.0%Sold out
Resources Investment Advisors, LLC.0$00.00%−29,783−100.0%Sold out
Traphagen Investment Advisors LLC0$00.00%−17,215−100.0%Sold out
Commonwealth Equity Services, LLC0$00.00%−14,182−100.0%Sold out
Two Sigma Investments, LP0$00.00%−13,409−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−1−100.0%Sold out